HSIL, High Grade Squamous Intraepithelial Lesions
8
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
Effect of HPV Integration on Prognosis of Young Women With CIN2 in China
Prognostic Study of HPV Virus Integration in Women With HSIL
ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS.
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Intraoperative HPV Testing Evaluation
E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSM
A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand